Year Established :
2007
Total Assets(USD) :
50,000,000 To 54,999,999
Total Number of Staff :
300 to 349
Main Competitive Advantages :
Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production capacity,Large Product Line,Contract Manufacturing,Buyers Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages :
Main products are dominated by hormone products such as dexamethasone, dexamethasone sodium phosphate, dexamethasone acetate, betamethasone, which have passed the national GMP certificate.
Business Type :
Manufacturer,Trading Company
Annual Turnover(USD) :
50,000,000 To 54,999,999
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Main Product Categorise :
Active Pharmaceutical Ingredients,Intermediates,Custom Manufacturing
Product Range :
API
---Dexamethasone
---Dexamethasone sod
---Dexamethasone ace
---Betamethasone
---Sofosbuvir
---6-Ethylchenodeoxy
---Medrogestone
---Nicergoline